Product Information
IBUPROFEN 400 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0397 per EA under NDC 59651036005. Its NADAC has been published 277 times since Mar 10, 2021.
Strength
400 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651036005
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA213794On Market Since
5/8/2020
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 400 MG TABLET has been published 277 times since Mar 10, 2021, and over the history we have for it it has declined 27.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0397 per EA |
|---|---|
| All-time high | $0.0577 (Sep 15, 2021) |
| All-time low | $0.0338 (Nov 20, 2024) |
| 52-week high | $0.0444 |
| 52-week low | $0.0387 |
| Median price | $0.0472 |
| Average price | $0.0465 |
| Largest weekly change | -25.2% (Nov 20, 2024) |
| Weeks tracked | 277 |
| Tracking since | Mar 10, 2021 |
Generic Alternatives
The matcher finds 14 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IBUPROFEN 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 400 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0397 per EA (NDC 59651036005), effective Jun 24, 2026.
How has the price of IBUPROFEN 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 400 MG TABLET has declined 27.1%. It has been tracked across 277 weekly CMS publications since Mar 10, 2021.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 400 MG TABLET?
Since Mar 10, 2021, the NADAC for IBUPROFEN 400 MG TABLET has ranged from a low of $0.0338 (Nov 20, 2024) to a high of $0.0577 (Sep 15, 2021), with a median of $0.0472 per EA.
Are there cheaper alternatives to IBUPROFEN 400 MG TABLET?
14 NADAC-published products share the same active ingredient, strength, and dosage form as IBUPROFEN 400 MG TABLET, but none are currently priced below it.
Who manufactures IBUPROFEN 400 MG TABLET?
IBUPROFEN 400 MG TABLET (NDC 59651036005) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification